Subscribe to our insights here so you can keep on top of the latest IP developments and updates.
The UK Supreme Court has reshaped software patent assessment, moving away from Aerotel toward greater EPO harmonisation and confirming that an ANN is
Two recent invalidity decisions show the risks of relying on online marketplace listings as prior art and demonstrate how design freedom shapes assess
From 1 January 2026, the UPC has increased its court fees by around 33%, with an additional 10% increase for Court of Appeal value-based fees, reflect
The UPC Court of Appeal has clarified its inventive step framework. We compare the UPC’s approach with the EPO’s Problem-Solution analysis, highli
An analysis of T-628/24, where the General Court upheld revocation of Lego’s EU design for a modified plate, questioning how informed users and subt
Boult has once again been featured in the World Trademark Review’s WTR 1000 for 2026.
The Brooklyn Beckham trade mark raises key questions about who controls a celebrity’s own name, the limits of the “own name” defence and the lon
We reflect on a year of life sciences innovation, highlighting Clarivate’s Drugs to Watch 2025, emerging therapy trends, AI-driven R&D and the evolv
The General Court overturned an EUIPO revocation, holding that proof of genuine use must be assessed holistically. It rejected excessive evidential bu
Partners Dr Joanna Peak and Marcus Sims are attending The Pharma & Biotech Patent Litigation Summit Europe on 19-21 January in Amsterdam.
An analysis of how the EPO Boards of Appeal and the UPC Munich Local Division assessed inventive step for Sanofi’s cabazitaxel patent and why they r
A UK court confirmed Dryrobe’s trade marks remain valid, ruling that rival D-ROBE infringed them. The case highlights the need for brand owners to p
With the Grinch leading major UK Christmas ads, brands are leveraging character merchandising and tight IP licensing to stand out in a £12bn festive
Boult represented Molecular Instruments (MI) before the Hague Local Division of the Unified Patent Court (UPC).
Welcome to this series focusing on graduate careers in intellectual property (IP) and at Boult. If you’re considering a role in IP,
Angela Stephen is attending LSPN Europe in London on 1 December. The event will focus on end-to-end patent lifecycle management.
Boult has been included in Band 1 by Chambers and Partners UK for both Patents and Trade Marks in its 2026 ranking.
Alex Stephenson is attending the CIPA Life Sciences Conference in London on 20 November.
Dr Jonathan Palmer is attending APAA Malaysia 2025 on 6-10 November in Kuala Lumpur.
From 1 January 2026, the UPC has increased its court fees by around 33%, with an additional 10% increase for Court of Appeal value-based fees, reflecting inflation and operational needs.
Boult has once again been featured in the World Trademark Review’s WTR 1000 for 2026.
Boult represented Molecular Instruments (MI) before the Hague Local Division of the Unified Patent Court (UPC).
Boult has been included in Band 1 by Chambers and Partners UK for both Patents and Trade Marks in its 2026 ranking.
Sign up to our insights so you can keep on top of the latest IP developments and updates.
SIGN UP
From 1 January 2026, the UPC has increased its court fees by around 33%, with an additional 10% increase for Court of Appeal value-based fees, reflecting inflation and operational needs.
Boult has once again been featured in the World Trademark Review’s WTR 1000 for 2026.
Boult represented Molecular Instruments (MI) before the Hague Local Division of the Unified Patent Court (UPC).
Boult has been included in Band 1 by Chambers and Partners UK for both Patents and Trade Marks in its 2026 ranking.
IPxNW is a leading networking event for professionals passionate about intellectual property across the North West — bringing together patent...
The Pharma & Biotech Patent Litigation Summit is a major European conference for life-sciences intellectual property professionals, focusing on patent...
LSPN Europe 2025 will focus on end-to-end patent lifecycle management, offering practical strategies for protecting and commercialising innovations in life...
The CIPA Life Sciences Conference is the leading UK event for IP professionals in the pharmaceutical, biotechnology and medical device...
APAA Malaysia 2025 will bring together IP professionals from across the Asia-Pacific region for a week of policy discussions, practical...
BIO-Europe 2025 is Europe’s premier annual partnering conference for the biotechnology, pharmaceutical and investment sectors. With over 5,000 attendees from...
The 12th Lsbc Central European Life Science Investment Conference top-level theme is: "The DNA of capital – Cracking the code...
Hosted jointly by the ABA Forum on the Entertainment & Sports Industries and the Section of Intellectual Property Law, this...
Organised by the Pharmaceutical Trademarks Group, this conference will bring together trademark professionals to discuss current challenges and opportunities in...
The Life Sciences Strategy Summit on IP & Exclusivity will convene legal and scientific experts to examine critical issues surrounding...
